Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
10343 | 1006 | 38.9 | 71% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
796 | 11443 | DRY POWDER INHALER//MUCOADHESION//JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | INHALED INSULIN | Author keyword | 94 | 80% | 6% | 59 |
2 | PULMONARY ABSORPTION | Author keyword | 54 | 64% | 5% | 53 |
3 | PULMONARY DELIVERY | Author keyword | 20 | 24% | 7% | 70 |
4 | EXUBERA | Author keyword | 14 | 100% | 1% | 7 |
5 | PULMONARY DRUG DISPOSITION | Author keyword | 12 | 86% | 1% | 6 |
6 | CALU 3 | Author keyword | 11 | 33% | 3% | 27 |
7 | EXUBERA R | Author keyword | 8 | 75% | 1% | 6 |
8 | CALU 3 CELL LINE | Author keyword | 8 | 100% | 0% | 5 |
9 | PULMONARY DRUG DELIVERY | Author keyword | 7 | 17% | 4% | 39 |
10 | AGGLOMERATED VESICLE TECHNOLOGY | Author keyword | 6 | 80% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | INHALED INSULIN | 94 | 80% | 6% | 59 | Search INHALED+INSULIN | Search INHALED+INSULIN |
2 | PULMONARY ABSORPTION | 54 | 64% | 5% | 53 | Search PULMONARY+ABSORPTION | Search PULMONARY+ABSORPTION |
3 | PULMONARY DELIVERY | 20 | 24% | 7% | 70 | Search PULMONARY+DELIVERY | Search PULMONARY+DELIVERY |
4 | EXUBERA | 14 | 100% | 1% | 7 | Search EXUBERA | Search EXUBERA |
5 | PULMONARY DRUG DISPOSITION | 12 | 86% | 1% | 6 | Search PULMONARY+DRUG+DISPOSITION | Search PULMONARY+DRUG+DISPOSITION |
6 | CALU 3 | 11 | 33% | 3% | 27 | Search CALU+3 | Search CALU+3 |
7 | EXUBERA R | 8 | 75% | 1% | 6 | Search EXUBERA+R | Search EXUBERA+R |
8 | CALU 3 CELL LINE | 8 | 100% | 0% | 5 | Search CALU+3+CELL+LINE | Search CALU+3+CELL+LINE |
9 | PULMONARY DRUG DELIVERY | 7 | 17% | 4% | 39 | Search PULMONARY+DRUG+DELIVERY | Search PULMONARY+DRUG+DELIVERY |
10 | AGGLOMERATED VESICLE TECHNOLOGY | 6 | 80% | 0% | 4 | Search AGGLOMERATED+VESICLE+TECHNOLOGY | Search AGGLOMERATED+VESICLE+TECHNOLOGY |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INHALED INSULIN | 46 | 49% | 7% | 69 |
2 | EXUBERA | 40 | 79% | 3% | 26 |
3 | DIABETES MANAGEMENT SYSTEM | 23 | 69% | 2% | 20 |
4 | INHALED HUMAN INSULIN | 20 | 53% | 3% | 27 |
5 | PULMONARY ABSORPTION | 20 | 50% | 3% | 29 |
6 | COMPARATIVE TRIAL | 16 | 19% | 8% | 79 |
7 | SUBCUTANEOUS INSULIN | 14 | 31% | 4% | 39 |
8 | PULMONARY SAFETY | 14 | 100% | 1% | 7 |
9 | CALU 3 CELLS | 12 | 42% | 2% | 22 |
10 | INTRATRACHEAL DELIVERY | 11 | 50% | 2% | 16 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Inhaled Technosphere Insulin: A Novel Delivery System and Formulation for the Treatment of Types 1 and 2 Diabetes Mellitus | 2015 | 2 | 27 | 89% |
Inhaled Insulin: A Breath of Fresh Air? A Review of Inhaled Insulin | 2014 | 6 | 27 | 93% |
Newer devices and improved formulations of inhaled insulin | 2015 | 1 | 48 | 73% |
In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery | 2006 | 121 | 127 | 60% |
The lung as a route for systemic delivery of therapeutic proteins and peptides | 2001 | 154 | 52 | 77% |
Technosphere Insulin (Afrezza): A New, Inhaled Prandial Insulin | 2015 | 1 | 15 | 53% |
INHALED INSULIN - DOES IT BECOME REALITY? | 2008 | 40 | 91 | 76% |
Inhaled insulin | 1999 | 146 | 36 | 58% |
Clinical pharmacokinetics and pharmacodynamics of inhaled insulin | 2004 | 94 | 42 | 64% |
A Review of Inhaled Technosphere Insulin | 2010 | 12 | 10 | 90% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TA PAIN CONTROL | 3 | 100% | 0.3% | 3 |
2 | RD CELL TISSUE BASED SYST | 2 | 67% | 0.2% | 2 |
3 | NANOTECHNOL BIOENGN | 2 | 21% | 0.8% | 8 |
4 | AEROSOL ALBERTA | 2 | 26% | 0.5% | 5 |
5 | ARMY MED RAWALPINDI | 1 | 50% | 0.2% | 2 |
6 | PL BIOMED ENGN PROGRAM | 1 | 50% | 0.2% | 2 |
7 | AEROSOL GRP | 1 | 24% | 0.5% | 5 |
8 | PHARMACEUT THER EUT | 1 | 12% | 0.9% | 9 |
9 | IMMUNE MODULAT GRP | 1 | 17% | 0.5% | 5 |
10 | FED DRUGS MED DEVICES | 1 | 20% | 0.4% | 4 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000256814 | DRY POWDER INHALER//DRY POWDER INHALATION//ADV DRUG DELIVERY GRP |
2 | 0.0000126146 | NASAL DELIVERY//NASAL DRUG DELIVERY//NASAL ABSORPTION |
3 | 0.0000119680 | NOVEL DRUG VACCINE DELIVERY SYST IL//INFECT DIS ANIM MODELS GRP//LIPOSOMAL ANTIBIOTIC |
4 | 0.0000112509 | LUNG MICROANGIOPATHY//RESTRICTIVE VENTILATORY DYSFUNCTION//HEPATOL EXPT FISIOL |
5 | 0.0000112232 | ORAL DELIVERY//ORAL INSULIN DELIVERY//ORAL INSULIN |
6 | 0.0000082050 | PULMONARY EPITHELIAL PERMEABILITY//ALVEOLAR PERMEABILITY//PERTECHNEGAS |
7 | 0.0000078806 | JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG//NEBULIZER//METERED DOSE INHALER |
8 | 0.0000068046 | ALVEOLAR EPITHELIUM//ALVEOLAR FLUID CLEARANCE//ALVEOLAR LIQUID CLEARANCE |
9 | 0.0000064503 | INSULIN GLARGINE//INSULIN DETEMIR//BIPHASIC INSULIN ASPART 30 |
10 | 0.0000062974 | GENE MED GRP//GENEMED GRP//EXPT TREATMENT CYST FIBROSIS |